Table 7 IMxRT series
IMRT Series | ||||||||
|---|---|---|---|---|---|---|---|---|
Author | Lee et al. | Wolden et al. | Kam et al. | Kwong et al. | Tham et al. | Lee et al. | Peponi et al. | Own data |
Year | 2002 | 2006 | 2004 | 2006 | 2009 | 2009 | 2010 | 2012 |
Institution | UCSF | MSKCC | PWH | QMH | NCC | RTOG0225 | USZ | DKFZ |
Region | USA | USA | Hongkong | Hongkong | Singapore | USA | Switzerland | Germany |
n | 67 | 74 | 63 | 50 | 195 | 68 | 39 | 49 |
f/u | 31 | 35 | 29 | 25 | 27 | 31 | 30 | 48 |
Stage III/IV | 70% | 77% | 57% | 100% | 56% | 59% | 85% | 72% |
sim. CHT | 75% | 93% | 25% | 68% | 57% | 83% | 97% | 100% |
adj. CHT | 75% | 93% | 0% | 68% | 35% | 83% | 97% | 0% |
TD | 65-70 | 70 | 66 | 76 | 70 | 70 | 66-70 | 66-70,4 |
SD | 2,12-2,25 | 2,34 o. CB | 2 | 2,17 | 2,0-2,12 | 2,12 | 2,0-2,2 | 2,2 |
add. Boosts | Br 40% | CB 80% | Br/3D 56% | none | Br 10% | none | none | none |
LC (year) | 96% (4y) | 91% (3y) | 92% (3y) | 96% (2y) | 90% (3y) | 93% (2y) | 86% (3y) | 90% (5y) |
RC (year) | 98% (4y) | 93% (3y) | 98% (3y) | n.r. | n.r. | 91% (2y) | 89% (3y) | 98% (5y) |
DC (year) | 66% (4y) | 78% (3y) | 79% (3y) | 94% (2y) | 89% (3y) | 85% (2y) | 85% (3y) | 86% (5y) |
OS (year) | 88% (4y) | 83% (3y) | 90% (3y) | 92% (2y) | 94% (3y) | 80% (2y) | 85% (3y) | 79% (5y) |